Mechanism-guided quantification of LINE-1 reveals p53 regulation of both retrotransposition and transcription
A. Solovyov, J. M. Behr, D. Hoyos, E. M. Banks, A. W. Drong, J. Z. Zhong, E. Garcia-Rivera, W. McKerrow, C. Chu, D. M. Zaller, M. Fromer, B. D. Greenbaum
Abstract
Somatic activity of LINE-1 (L1) mobile elements has been implicated in cancer etiology, which may be related to the loss of p53-mediated regulation as a result of TP53 mutations. Quantifying the mechanisms of L1 regulation in cancer has been challenging. Here, we build a statistical model of L1 regulation by simultaneously quantifying L1 retrotransposition, L1 expression, and the fitness costs of mutated TP53 with precision. We first developed Total ReCall, an algorithm specifically tailored to the mechanisms of L1 reintegration, to detect L1 insertions from short-read whole-genome sequencing. Applying Total ReCall to high-quality data consisting of >750 paired tumor and normal samples from The Cancer Genome Atlas (TCGA) shows high L1 insertion heterogeneity among tumor types, with increased retrotransposition burden in lung squamous cell carcinoma, head and neck, and colon cancers. We next assessed the active RNA expression of intact L1 in >9,000 TCGA tumor samples, establishing, for the first time, a clear correlation between L1 expression and retrotransposition. Finally, we integrated the number of L1 insertions, L1 expression and a mathematical model of TP53 fitness into a multi-modal model of p53- mediated mechanisms of L1 regulation. We show that TP53 mutations enable retrotransposition both by disinhibiting L1 expression and enabling its reintegration and quantify the relative weights of this dual regulatory role. We demonstrate how mechanism-based multi-modal modeling applied at scale can statistically disentangle the complex interplay between canonical driver events in tumor evolution and retrotransposon activity.
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Pan-cancer analysis of whole genomes reveals driver rearrangements promoted by LINE-1 retrotransposition in human tumours
Bernardo Rodríguez–Martín, Eva G. Álvarez, … the ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Network·bioRxiv·Sep 7, 2018
- p53 mediated regulation of LINE1 retrotransposon derived R-loops
Pratyashaa Paul, Arun Kumar, … Bhavana Tiwari·Journal of Biological ChemistryPeer-reviewed·Jan 17, 2025
- Intrahepatic reporter assay reveals leaky somatic blockade of L1 retrotransposition in mice
May Raya, Réka Karkas, … Lajos Mátés·bioRxiv·Feb 12, 2026
- BRCA1 Mediated Homologous Recombination and S Phase DNA Repair Pathways Restrict LINE-1 Retrotransposition in Human Cells
X. Sun, P. Mita, … J. D. Boeke·bioRxiv·Jul 13, 2019
- Immune signatures correlate with L1 retrotransposition in gastrointestinal cancers
Hyunchul Jung, Jung Kyoon Choi, Eunjung Alice Lee·Genome ResearchPeer-reviewed·Aug 1, 2018
- The tumor suppressor microRNA let-7 inhibits human LINE-1 retrotransposition
Pablo Tristán-Ramos, Alejandro Rubio-Roldán, … Sara R. Heras·Nature CommunicationsPeer-reviewed·Nov 11, 2020